At the recent USP’s China Nitrosamines Workshop, Dr. David Ponting @David lead the presentation “How Concerning is your nitrosamine? Using SAR to evaluate hazard and potency” @jxl
To understand questions like: How can DATA sharing benefit the entire industry on correlating and identifying trends when it comes to SAR evaluation? How good is the AMES test? How about Carcinogenicity Potency of Nitrosamines? The importance of the Activation Mechanism? Does SAR feature play a role when predicting mutagenicity?
